• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于片段的分子动力学方法研究 G 蛋白偶联受体的变构可成药性口袋。

Mapping the druggable allosteric space of G-protein coupled receptors: a fragment-based molecular dynamics approach.

机构信息

Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA.

出版信息

Chem Biol Drug Des. 2010 Sep 1;76(3):201-17. doi: 10.1111/j.1747-0285.2010.01012.x. Epub 2010 Jul 5.

DOI:10.1111/j.1747-0285.2010.01012.x
PMID:20626410
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2918726/
Abstract

To address the problem of specificity in G-protein coupled receptor (GPCR) drug discovery, there has been tremendous recent interest in allosteric drugs that bind at sites topographically distinct from the orthosteric site. Unfortunately, structure-based drug design of allosteric GPCR ligands has been frustrated by the paucity of structural data for allosteric binding sites, making a strong case for predictive computational methods. In this work, we map the surfaces of the beta1 (beta1AR) and beta2 (beta2AR) adrenergic receptor structures to detect a series of five potentially druggable allosteric sites. We employ the FTMAP algorithm to identify 'hot spots' with affinity for a variety of organic probe molecules corresponding to drug fragments. Our work is distinguished by an ensemble-based approach, whereby we map diverse receptor conformations taken from molecular dynamics (MD) simulations totaling approximately 0.5 micros. Our results reveal distinct pockets formed at both solvent-exposed and lipid-exposed cavities, which we interpret in light of experimental data and which may constitute novel targets for GPCR drug discovery. This mapping data can now serve to drive a combination of fragment-based and virtual screening approaches for the discovery of small molecules that bind at these sites and which may offer highly selective therapies.

摘要

为了解决 G 蛋白偶联受体 (GPCR) 药物发现中特异性的问题,人们最近对结合在变构部位而非正位部位的变构药物产生了浓厚的兴趣。不幸的是,由于变构结合部位的结构数据稀缺,基于结构的变构 GPCR 配体药物设计受到了阻碍,这强烈需要预测性计算方法。在这项工作中,我们将β1(β1AR)和β2(β2AR)肾上腺素能受体结构的表面进行映射,以检测一系列五个潜在可成药的变构部位。我们采用 FTMAP 算法来识别与各种有机探针分子(对应于药物片段)具有亲和力的“热点”。我们的工作的特点是采用基于集合的方法,我们从分子动力学(MD)模拟中映射了来自不同受体构象的集合,模拟总时长约为 0.5 微秒。我们的结果揭示了在溶剂暴露和脂质暴露腔中形成的不同口袋,我们根据实验数据对其进行了解释,这些口袋可能构成 GPCR 药物发现的新靶标。现在,这些映射数据可用于驱动基于片段和虚拟筛选方法的小分子发现,这些小分子可以结合这些部位,并提供高度选择性的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/260111cf8335/cbdd0076-0201-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/f09929f2b772/cbdd0076-0201-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/d6989196b4b4/cbdd0076-0201-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/314af956b725/cbdd0076-0201-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/852c99d81a3d/cbdd0076-0201-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/21dc151fac99/cbdd0076-0201-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/0afa402edc36/cbdd0076-0201-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/dfef9e17ef04/cbdd0076-0201-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/fe0f36208109/cbdd0076-0201-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/260111cf8335/cbdd0076-0201-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/f09929f2b772/cbdd0076-0201-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/d6989196b4b4/cbdd0076-0201-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/314af956b725/cbdd0076-0201-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/852c99d81a3d/cbdd0076-0201-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/21dc151fac99/cbdd0076-0201-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/0afa402edc36/cbdd0076-0201-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/dfef9e17ef04/cbdd0076-0201-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/fe0f36208109/cbdd0076-0201-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa53/3563230/260111cf8335/cbdd0076-0201-f9.jpg

相似文献

1
Mapping the druggable allosteric space of G-protein coupled receptors: a fragment-based molecular dynamics approach.基于片段的分子动力学方法研究 G 蛋白偶联受体的变构可成药性口袋。
Chem Biol Drug Des. 2010 Sep 1;76(3):201-17. doi: 10.1111/j.1747-0285.2010.01012.x. Epub 2010 Jul 5.
2
A molecular dynamics ensemble-based approach for the mapping of druggable binding sites.一种基于分子动力学系综的可成药结合位点映射方法。
Methods Mol Biol. 2012;819:3-12. doi: 10.1007/978-1-61779-465-0_1.
3
Mapping of allosteric druggable sites in activation-associated conformers of the M2 muscarinic receptor.M2毒蕈碱受体激活相关构象中变构可药物化位点的映射。
Chem Biol Drug Des. 2014 Feb;83(2):237-46. doi: 10.1111/cbdd.12233. Epub 2013 Oct 30.
4
Dynamical Correlations Reveal Allosteric Sites in G Protein-Coupled Receptors.动态相关揭示 G 蛋白偶联受体中的变构位点。
Int J Mol Sci. 2020 Dec 27;22(1):187. doi: 10.3390/ijms22010187.
5
Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.G蛋白偶联受体变构调节剂发现中的机遇与挑战
Methods Mol Biol. 2018;1705:297-319. doi: 10.1007/978-1-4939-7465-8_13.
6
Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.双靶点配体与亚稳结合位点:G蛋白偶联受体(GPCR)药物化学的机遇
J Med Chem. 2017 May 25;60(10):4126-4134. doi: 10.1021/acs.jmedchem.6b01601. Epub 2017 Feb 15.
7
Comparative Study of Allosteric GPCR Binding Sites and Their Ligandability Potential.变构 GPCR 结合位点及其配体结合潜力的比较研究。
J Chem Inf Model. 2024 Nov 11;64(21):8176-8192. doi: 10.1021/acs.jcim.4c00819. Epub 2024 Oct 23.
8
Application of Mixed-Solvent Molecular Dynamics Simulations for Prediction of Allosteric Sites on G Protein-Coupled Receptors.混合溶剂分子动力学模拟在 G 蛋白偶联受体变构位点预测中的应用。
Mol Pharmacol. 2023 May;103(5):274-285. doi: 10.1124/molpharm.122.000612. Epub 2023 Mar 3.
9
Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors.变构配体结合位点在 G 蛋白偶联受体中的保守性。
J Chem Inf Model. 2022 Oct 24;62(20):4937-4954. doi: 10.1021/acs.jcim.2c00209. Epub 2022 Oct 4.
10
Recent Insights from Molecular Dynamics Simulations for G Protein-Coupled Receptor Drug Discovery.从分子动力学模拟看 G 蛋白偶联受体药物研发的新进展。
Int J Mol Sci. 2019 Aug 29;20(17):4237. doi: 10.3390/ijms20174237.

引用本文的文献

1
A non-canonical mechanism of GPCR activation.G 蛋白偶联受体激活的非经典机制。
Nat Commun. 2024 Nov 16;15(1):9938. doi: 10.1038/s41467-024-54103-6.
2
Exploring Druggable Binding Sites on the Class A GPCRs Using the Residue Interaction Network and Site Identification by Ligand Competitive Saturation.利用残基相互作用网络和配体竞争饱和法鉴定A类G蛋白偶联受体上的可成药结合位点
ACS Omega. 2024 Sep 13;9(38):40154-40171. doi: 10.1021/acsomega.4c06172. eCollection 2024 Sep 24.
3
Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition.

本文引用的文献

1
Rational design of dualsteric GPCR ligands: quests and promise.双位构象 G 蛋白偶联受体配体的合理设计:探索与展望。
Br J Pharmacol. 2010 Mar;159(5):997-1008. doi: 10.1111/j.1476-5381.2009.00601.x. Epub 2010 Feb 5.
2
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor.配体特异性调节 G 蛋白偶联受体的细胞外表面。
Nature. 2010 Jan 7;463(7277):108-12. doi: 10.1038/nature08650.
3
The impact of GPCR structures on pharmacology and structure-based drug design.G 蛋白偶联受体结构对药理学和基于结构的药物设计的影响。
了解你的分子:候选药物的药理学特征,以提高疗效并减少后期损耗。
Nat Rev Drug Discov. 2024 Aug;23(8):626-644. doi: 10.1038/s41573-024-00958-9. Epub 2024 Jun 18.
4
Toward physics-based precision medicine: Exploiting protein dynamics to design new therapeutics and interpret variants.迈向基于物理学的精准医学:利用蛋白质动力学设计新的治疗方法和解释变体。
Protein Sci. 2024 Mar;33(3):e4902. doi: 10.1002/pro.4902.
5
Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands.别构调节 G 蛋白偶联受体:从分子机制多样性到多个别构结合位点及其配体。
Int J Mol Sci. 2023 Mar 24;24(7):6187. doi: 10.3390/ijms24076187.
6
Activity Map and Transition Pathways of G Protein-Coupled Receptor Revealed by Machine Learning.机器学习揭示的 G 蛋白偶联受体的活动图谱和跃迁途径。
J Chem Inf Model. 2023 Apr 24;63(8):2296-2304. doi: 10.1021/acs.jcim.3c00032. Epub 2023 Apr 10.
7
Predicting locations of cryptic pockets from single protein structures using the PocketMiner graph neural network.利用 PocketMiner 图神经网络从单个蛋白质结构预测隐匿口袋的位置。
Nat Commun. 2023 Mar 1;14(1):1177. doi: 10.1038/s41467-023-36699-3.
8
Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors.变构配体结合位点在 G 蛋白偶联受体中的保守性。
J Chem Inf Model. 2022 Oct 24;62(20):4937-4954. doi: 10.1021/acs.jcim.2c00209. Epub 2022 Oct 4.
9
An Evolutionary Conservation and Druggability Analysis of Enzymes Belonging to the Bacterial Shikimate Pathway.细菌莽草酸途径中酶的进化保守性与成药性分析
Antibiotics (Basel). 2022 May 17;11(5):675. doi: 10.3390/antibiotics11050675.
10
Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8.分子动力学模拟揭示了结构相似激动剂对 TLR7 和 TLR8 的选择性作用机制。
PLoS One. 2022 Apr 22;17(4):e0260565. doi: 10.1371/journal.pone.0260565. eCollection 2022.
Br J Pharmacol. 2010 Mar;159(5):986-96. doi: 10.1111/j.1476-5381.2009.00476.x. Epub 2009 Nov 13.
4
Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors.将受体柔性和诱导契合效应纳入 MMP-2 抑制剂的设计中。
J Mol Recognit. 2010 Mar-Apr;23(2):173-82. doi: 10.1002/jmr.989.
5
Computational approaches to identifying and characterizing protein binding sites for ligand design.计算方法在识别和描述配体设计的蛋白质结合部位中的应用。
J Mol Recognit. 2010 Mar-Apr;23(2):209-19. doi: 10.1002/jmr.984.
6
Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders.G蛋白偶联受体的变构调节剂:针对复杂生理紊乱的未来疗法。
J Pharmacol Exp Ther. 2009 Nov;331(2):340-8. doi: 10.1124/jpet.109.156380. Epub 2009 Aug 10.
7
Ligands, their receptors and ... plasma membranes.配体、它们的受体和……质膜。
Mol Cell Endocrinol. 2009 Nov 13;311(1-2):1-10. doi: 10.1016/j.mce.2009.07.022. Epub 2009 Jul 30.
8
Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.正构/别构双位点配体:在G蛋白偶联受体领域走向混合型
Mol Interv. 2009 Jun;9(3):125-35. doi: 10.1124/mi.9.3.6.
9
Detection of ligand binding hot spots on protein surfaces via fragment-based methods: application to DJ-1 and glucocerebrosidase.基于片段的方法检测蛋白质表面的配体结合热点:在 DJ-1 和葡萄糖脑苷脂酶中的应用。
J Comput Aided Mol Des. 2009 Aug;23(8):491-500. doi: 10.1007/s10822-009-9283-2. Epub 2009 Jun 12.
10
Structure-based discovery of beta2-adrenergic receptor ligands.基于结构的β2-肾上腺素能受体配体的发现
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6843-8. doi: 10.1073/pnas.0812657106. Epub 2009 Apr 2.